Corticotropin-Releasing Factor receptor 1 (CRF1) antagonism in patients with alcohol use disorder and high anxiety levels: effect on neural response during Trier Social Stress Test video feedback

In preclinical models of alcohol use disorder, the corticotropin-releasing factor (CRF) receptor is upregulated, particularly in the extended amygdala. This upregulation is thought to play a role in stress-induced relapse to drinking by a mechanism that is independent of the hypothalamic-pituitary-a...

Full description

Saved in:
Bibliographic Details
Published inNeuropsychopharmacology (New York, N.Y.) Vol. 48; no. 5; pp. 816 - 820
Main Authors Lee, Mary R., Rio, Daniel, Kwako, Laura, George, David T., Heilig, Markus, Momenan, Reza
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 01.04.2023
Springer International Publishing
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In preclinical models of alcohol use disorder, the corticotropin-releasing factor (CRF) receptor is upregulated, particularly in the extended amygdala. This upregulation is thought to play a role in stress-induced relapse to drinking by a mechanism that is independent of the hypothalamic-pituitary-adrenal axis. As part of a double-blind, placebo-controlled clinical study with pexacerfont, a selective, orally available, and brain-penetrant CRF1 receptor antagonist which has anti-anxiety effects in preclinical studies, we examined the effect of pexacerfont on the neural response to a social stress task adapted to fMRI. Subjects were 39 individuals (4 women) with high trait anxiety and moderate to severe alcohol use disorder randomized to receive pexacerfont or placebo. The task involved feedback of videoclips of an individual performing the Trier Social Stress Test. Pexacerfont had no effect on the neural response to self-observation under stress. The neural response to viewing oneself under stress vs an unknown other under stress activated prefrontal brain regions including insula, inferior frontal gyrus as well as medial, superior frontal gyri. These regions of activation overlap with those found in studies using similar paradigms. Potential applications of this task to probe neurocircuitry that is disrupted in addiction is discussed.
AbstractList In preclinical models of alcohol use disorder, the corticotropin-releasing factor (CRF) receptor is upregulated, particularly in the extended amygdala. This upregulation is thought to play a role in stress-induced relapse to drinking by a mechanism that is independent of the hypothalamic-pituitary-adrenal axis. As part of a double-blind, placebo-controlled clinical study with pexacerfont, a selective, orally available, and brain-penetrant CRF1 receptor antagonist which has anti-anxiety effects in preclinical studies, we examined the effect of pexacerfont on the neural response to a social stress task adapted to fMRI. Subjects were 39 individuals (4 women) with high trait anxiety and moderate to severe alcohol use disorder randomized to receive pexacerfont or placebo. The task involved feedback of videoclips of an individual performing the Trier Social Stress Test. Pexacerfont had no effect on the neural response to self-observation under stress. The neural response to viewing oneself under stress vs an unknown other under stress activated prefrontal brain regions including insula, inferior frontal gyrus as well as medial, superior frontal gyri. These regions of activation overlap with those found in studies using similar paradigms. Potential applications of this task to probe neurocircuitry that is disrupted in addiction is discussed.
In preclinical models of alcohol use disorder, the corticotropin-releasing factor (CRF) receptor is upregulated, particularly in the extended amygdala. This upregulation is thought to play a role in stress-induced relapse to drinking by a mechanism that is independent of the hypothalamic-pituitary-adrenal axis. As part of a double-blind, placebo-controlled clinical study with pexacerfont, a selective, orally available, and brain-penetrant CRF1 receptor antagonist which has anti-anxiety effects in preclinical studies, we examined the effect of pexacerfont on the neural response to a social stress task adapted to fMRI. Subjects were 39 individuals (4 women) with high trait anxiety and moderate to severe alcohol use disorder randomized to receive pexacerfont or placebo. The task involved feedback of videoclips of an individual performing the Trier Social Stress Test. Pexacerfont had no effect on the neural response to self-observation under stress. The neural response to viewing oneself under stress vs an unknown other under stress activated prefrontal brain regions including insula, inferior frontal gyrus as well as medial, superior frontal gyri. These regions of activation overlap with those found in studies using similar paradigms. Potential applications of this task to probe neurocircuitry that is disrupted in addiction is discussed.In preclinical models of alcohol use disorder, the corticotropin-releasing factor (CRF) receptor is upregulated, particularly in the extended amygdala. This upregulation is thought to play a role in stress-induced relapse to drinking by a mechanism that is independent of the hypothalamic-pituitary-adrenal axis. As part of a double-blind, placebo-controlled clinical study with pexacerfont, a selective, orally available, and brain-penetrant CRF1 receptor antagonist which has anti-anxiety effects in preclinical studies, we examined the effect of pexacerfont on the neural response to a social stress task adapted to fMRI. Subjects were 39 individuals (4 women) with high trait anxiety and moderate to severe alcohol use disorder randomized to receive pexacerfont or placebo. The task involved feedback of videoclips of an individual performing the Trier Social Stress Test. Pexacerfont had no effect on the neural response to self-observation under stress. The neural response to viewing oneself under stress vs an unknown other under stress activated prefrontal brain regions including insula, inferior frontal gyrus as well as medial, superior frontal gyri. These regions of activation overlap with those found in studies using similar paradigms. Potential applications of this task to probe neurocircuitry that is disrupted in addiction is discussed.
Author Rio, Daniel
Momenan, Reza
Heilig, Markus
Lee, Mary R.
George, David T.
Kwako, Laura
Author_xml – sequence: 1
  givenname: Mary R.
  surname: Lee
  fullname: Lee, Mary R.
– sequence: 2
  givenname: Daniel
  surname: Rio
  fullname: Rio, Daniel
– sequence: 3
  givenname: Laura
  orcidid: 0000-0003-1899-2098
  surname: Kwako
  fullname: Kwako, Laura
– sequence: 4
  givenname: David T.
  surname: George
  fullname: George, David T.
– sequence: 5
  givenname: Markus
  surname: Heilig
  fullname: Heilig, Markus
– sequence: 6
  givenname: Reza
  orcidid: 0000-0002-7624-9676
  surname: Momenan
  fullname: Momenan, Reza
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36564531$$D View this record in MEDLINE/PubMed
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-191201$$DView record from Swedish Publication Index
BookMark eNp9ksFu1DAQhi1URLeFF-CALHEph4AdJ07CBVULC5UqIbUL6s1ynMmui9cOtrOlfT1eDKfbItoDJ1ua7x__M_4P0J51FhB6SclbSlj9LhSU1TwjeZ4RWuY0u3mCZrQqSMZZcbGHZqRuWEYZu9hHByFckkRVvH6G9hkveVEyOkO_585HrVz0btA2OwMDMmi7wgupovPYg4JhulB8ND9b0DdY2ihXzuqwwdriQUYNNgZ8peMaS6Pc2hk8BsCdDs534JOgw2u9SlX7S0O8xga2YMJ7DH0PKmJnsYXRS5MeC4Ozk3b0k4el10l_7pROxfOYygEvIUS81R043AN0rVQ_nqOnvTQBXtydh-jb4tNy_iU7_fr5ZH58mqmCNzFroOkKIJWUvAWQPauroqtJRVopSUkZqXKiZFco1lBV9FVXKQY1LxjrStq0LTtE2a5vuIJhbMXg9Ub6a-GkFh_192Ph_EoYPQra0JzQxH_Y8QneQKfSntKUD2QPK1avxcptBSWE87ypUoejuw7e_RzT5GKjgwJjpAU3BpFXZU0pb_j02OtH6KUbvU37SFTDcl6nUCTq1b-W_nq5D0QC6h2gvAvBQy-UjumP3eRQm2RNTNkTu-yJlD1xmz1xk6T5I-l99_-I_gDrYOEg
CitedBy_id crossref_primary_10_1038_s41386_023_01539_x
crossref_primary_10_1038_s41386_023_01693_2
Cites_doi 10.1002/da.20695
10.1016/j.neuron.2016.11.034
10.1007/s002130000411
10.1207/s15327752jpa6801_7
10.1016/j.neuron.2018.03.048
10.1016/j.neuroimage.2014.06.027
10.3389/fpsyg.2018.01825
10.1037/1040-3590.19.1.119
10.1037/bne0000305
10.1006/cbmr.1996.0014
10.1111/j.1530-0277.2011.01452.x
10.1016/j.neubiorev.2015.12.003
10.1037/t05183-000
10.1016/j.neuropsychologia.2013.11.022
10.1016/S0145-2134(02)00541-0
10.1159/000119004
10.1176/appi.books.9780890425596
10.1038/s41598-018-32828-x
10.1016/j.biopsych.2013.02.026
10.1016/j.pscychresns.2018.12.016
10.1196/annals.1314.032
10.1002/hbm.20168
10.1093/alcalc/agab062
10.1002/jts.2490060405
10.3389/fpsyt.2022.893833
10.1007/s00213-007-0905-x
10.1176/appi.ajp.2008.07071199
10.1016/j.tins.2007.06.006
10.1523/JNEUROSCI.4985-06.2007
10.1038/npp.2014.306
10.1111/j.1530-0277.1995.tb01554.x
10.1016/j.drugalcdep.2012.12.017
10.1016/0006-8993(93)91352-S
10.1037/t06496-000
10.1016/j.pscychresns.2018.12.017
ContentType Journal Article
Copyright 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022.
This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022
Copyright_xml – notice: 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
– notice: This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022.
– notice: This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
88G
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2M
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
ADTPV
AOWAS
DG8
DOI 10.1038/s41386-022-01521-z
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Psychology Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
SwePub
SwePub Articles
SWEPUB Linköpings universitet
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

ProQuest One Psychology

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1740-634X
EndPage 820
ExternalDocumentID oai_DiVA_org_liu_191201
PMC10066297
36564531
10_1038_s41386_022_01521_z
Genre Randomized Controlled Trial
Journal Article
Research Support, N.I.H., Intramural
GrantInformation_xml – fundername: ;
GroupedDBID ---
-DZ
0R~
29N
2WC
36B
39C
4.4
406
5RE
70F
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AACDK
AANZL
AASML
AATNV
AAYXX
AAYZH
ABAKF
ABBRH
ABDBE
ABFSG
ABIVO
ABJNI
ABLJU
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMFV
ACMJI
ACPRK
ACSTC
ACZOJ
ADBBV
ADFRT
AEFQL
AEJRE
AEMSY
AENEX
AESKC
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AHWEU
AIGIU
AILAN
AIXLP
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AOIJS
ASPBG
ATHPR
AVWKF
AYFIA
AZFZN
AZQEC
BAWUL
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CITATION
CS3
DIK
DNIVK
DPUIP
DWQXO
E3Z
EBLON
EBS
EE.
F5P
FDB
FDQFY
FIGPU
FYUFA
GNUQQ
GX1
HCIFZ
HMCUK
HYE
HZ~
IWAJR
JSO
JZLTJ
KQ8
LGEZI
LOTEE
M1P
M2M
M7P
NADUK
NQJWS
NXXTH
O9-
OK1
P2P
P6G
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
PSYQQ
Q2X
RNT
RNTTT
ROL
RPM
SNX
SNYQT
SOJ
SRMVM
SWTZT
TAOOD
TR2
UKHRP
W2D
ZGI
--K
-Q-
1B1
53G
5VS
AAEDT
AALRI
AAQFI
AAQXK
AAXUO
ABMAC
ABRTQ
ABWVN
ACIUM
ACRPL
ACRQY
ACVFH
ADCNI
ADMUD
ADNMO
AEUPX
AFPUW
AGQPQ
CAG
CGR
COF
CUY
CVF
ECM
EIF
EIOEI
EJD
EMB
EMOBN
FEDTE
FERAY
FGOYB
FIZPM
FSGXE
HVGLF
IHE
M41
MK0
NPM
NQ-
PJZUB
PPXIY
PQGLB
R2-
RIG
RNS
RPZ
SEW
SOHCF
SSZ
SV3
TBHMF
TDRGL
ZKB
3V.
7TK
7XB
8FE
8FH
8FK
K9.
LK8
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ADTPV
AOWAS
DG8
ID FETCH-LOGICAL-c469t-9e9d4e07aa6beeaf3874d8070baa05130720cad4c391c4f7d7c3e86433d519bb3
IEDL.DBID 7X7
ISSN 0893-133X
1740-634X
IngestDate Thu Aug 21 06:24:38 EDT 2025
Thu Aug 21 18:35:00 EDT 2025
Thu Jul 10 23:33:31 EDT 2025
Fri Jul 25 08:56:21 EDT 2025
Mon Jul 21 06:02:46 EDT 2025
Tue Jul 01 01:05:45 EDT 2025
Thu Apr 24 22:58:55 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c469t-9e9d4e07aa6beeaf3874d8070baa05130720cad4c391c4f7d7c3e86433d519bb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ORCID 0000-0003-1899-2098
0000-0002-7624-9676
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/10066297
PMID 36564531
PQID 2793268634
PQPubID 33935
PageCount 5
ParticipantIDs swepub_primary_oai_DiVA_org_liu_191201
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10066297
proquest_miscellaneous_2758116961
proquest_journals_2793268634
pubmed_primary_36564531
crossref_citationtrail_10_1038_s41386_022_01521_z
crossref_primary_10_1038_s41386_022_01521_z
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-04-01
PublicationDateYYYYMMDD 2023-04-01
PublicationDate_xml – month: 04
  year: 2023
  text: 2023-04-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: New York
– name: Cham
PublicationTitle Neuropsychopharmacology (New York, N.Y.)
PublicationTitleAlternate Neuropsychopharmacology
PublicationYear 2023
Publisher Nature Publishing Group
Springer International Publishing
Publisher_xml – name: Nature Publishing Group
– name: Springer International Publishing
References AD Lê (1521_CR9) 2000; 150
PT Costa Jr (1521_CR24) 1997; 68
C Galandra (1521_CR32) 2018; 8
S Rassnick (1521_CR7) 1993; 605
AI Alterman (1521_CR22) 2007; 19
1521_CR14
G Chen (1521_CR27) 2014; 99
1521_CR15
V Coric (1521_CR6) 2010; 27
LE Kwako (1521_CR11) 2015; 40
C Kirschbaum (1521_CR12) 1993; 28
EB Foa (1521_CR28) 1993; 6
TC Durazzo (1521_CR33) 2011; 35
EV Sullivan (1521_CR35) 2013; 74
RW Cox (1521_CR26) 1996; 29
PW Marinelli (1521_CR10) 2007; 195
CB Padula (1521_CR37) 2022; 13
DP Bernstein (1521_CR23) 2003; 27
CA Sanford (1521_CR2) 2017; 93
SM Platek (1521_CR29) 2006; 27
TJ Butcher (1521_CR36) 2021; 57
F Benuzzi (1521_CR30) 2018; 9
1521_CR25
EP Zorrilla (1521_CR4) 2013; 128
LA Brown (1521_CR18) 2019; 284
1521_CR21
TR Orem (1521_CR19) 2019; 133
1521_CR1
DR Gehlert (1521_CR8) 2007; 27
MJ Bohn (1521_CR16) 1995; 19
C Hu (1521_CR20) 2016; 61
B Binneman (1521_CR5) 2008; 165
MR Lee (1521_CR17) 2014; 53
R Sinha (1521_CR13) 2004; 1032
M Heilig (1521_CR3) 2007; 30
A Zilverstand (1521_CR31) 2018; 98
ME Halcomb (1521_CR34) 2019; 284
36725866 - Neuropsychopharmacology. 2023 Apr;48(5):711-712
References_xml – volume: 27
  start-page: 417
  year: 2010
  ident: 1521_CR6
  publication-title: Depress Anxiety
  doi: 10.1002/da.20695
– ident: 1521_CR25
– volume: 93
  start-page: 164
  year: 2017
  ident: 1521_CR2
  publication-title: Neuron
  doi: 10.1016/j.neuron.2016.11.034
– volume: 150
  start-page: 317
  year: 2000
  ident: 1521_CR9
  publication-title: Psychopharmacology
  doi: 10.1007/s002130000411
– volume: 68
  start-page: 86
  year: 1997
  ident: 1521_CR24
  publication-title: J Pers Assess
  doi: 10.1207/s15327752jpa6801_7
– volume: 98
  start-page: 886
  year: 2018
  ident: 1521_CR31
  publication-title: Neuron
  doi: 10.1016/j.neuron.2018.03.048
– volume: 99
  start-page: 571
  year: 2014
  ident: 1521_CR27
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2014.06.027
– volume: 9
  start-page: 1825
  year: 2018
  ident: 1521_CR30
  publication-title: Front Psychol
  doi: 10.3389/fpsyg.2018.01825
– volume: 19
  start-page: 119
  year: 2007
  ident: 1521_CR22
  publication-title: Psychol Assess
  doi: 10.1037/1040-3590.19.1.119
– volume: 133
  start-page: 203
  year: 2019
  ident: 1521_CR19
  publication-title: Behav Neurosci
  doi: 10.1037/bne0000305
– volume: 29
  start-page: 162
  year: 1996
  ident: 1521_CR26
  publication-title: Comput Biomed Res
  doi: 10.1006/cbmr.1996.0014
– volume: 35
  start-page: 1187
  year: 2011
  ident: 1521_CR33
  publication-title: Alcohol Clin Exp Res
  doi: 10.1111/j.1530-0277.2011.01452.x
– volume: 61
  start-page: 197
  year: 2016
  ident: 1521_CR20
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2015.12.003
– ident: 1521_CR15
  doi: 10.1037/t05183-000
– volume: 53
  start-page: 257
  year: 2014
  ident: 1521_CR17
  publication-title: Neuropsychologia
  doi: 10.1016/j.neuropsychologia.2013.11.022
– volume: 27
  start-page: 169
  year: 2003
  ident: 1521_CR23
  publication-title: Child Abus Negl
  doi: 10.1016/S0145-2134(02)00541-0
– volume: 28
  start-page: 76
  year: 1993
  ident: 1521_CR12
  publication-title: Neuropsychobiology
  doi: 10.1159/000119004
– ident: 1521_CR1
  doi: 10.1176/appi.books.9780890425596
– volume: 8
  year: 2018
  ident: 1521_CR32
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-32828-x
– volume: 74
  start-page: 547
  year: 2013
  ident: 1521_CR35
  publication-title: Biol psychiatry
  doi: 10.1016/j.biopsych.2013.02.026
– volume: 284
  start-page: 21
  year: 2019
  ident: 1521_CR34
  publication-title: Psychiatry Res: Neuroimaging
  doi: 10.1016/j.pscychresns.2018.12.016
– volume: 1032
  start-page: 254
  year: 2004
  ident: 1521_CR13
  publication-title: Ann NY Acad Sci
  doi: 10.1196/annals.1314.032
– ident: 1521_CR14
– volume: 27
  start-page: 91
  year: 2006
  ident: 1521_CR29
  publication-title: Hum Brain Mapp
  doi: 10.1002/hbm.20168
– volume: 57
  start-page: 445
  year: 2021
  ident: 1521_CR36
  publication-title: Alcohol Alcohol
  doi: 10.1093/alcalc/agab062
– volume: 6
  start-page: 459
  year: 1993
  ident: 1521_CR28
  publication-title: J Trauma Stress
  doi: 10.1002/jts.2490060405
– volume: 13
  start-page: 893833
  year: 2022
  ident: 1521_CR37
  publication-title: Front Psychiatry
  doi: 10.3389/fpsyt.2022.893833
– volume: 195
  start-page: 345
  year: 2007
  ident: 1521_CR10
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-007-0905-x
– volume: 165
  start-page: 617
  year: 2008
  ident: 1521_CR5
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2008.07071199
– volume: 30
  start-page: 399
  year: 2007
  ident: 1521_CR3
  publication-title: Trends Neurosci
  doi: 10.1016/j.tins.2007.06.006
– volume: 27
  start-page: 2718
  year: 2007
  ident: 1521_CR8
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.4985-06.2007
– volume: 40
  start-page: 1053
  year: 2015
  ident: 1521_CR11
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2014.306
– volume: 19
  start-page: 600
  year: 1995
  ident: 1521_CR16
  publication-title: Alcohol: Clin Exp Res
  doi: 10.1111/j.1530-0277.1995.tb01554.x
– volume: 128
  start-page: 175
  year: 2013
  ident: 1521_CR4
  publication-title: Drug Alcohol Depend
  doi: 10.1016/j.drugalcdep.2012.12.017
– volume: 605
  start-page: 25
  year: 1993
  ident: 1521_CR7
  publication-title: Brain Res
  doi: 10.1016/0006-8993(93)91352-S
– ident: 1521_CR21
  doi: 10.1037/t06496-000
– volume: 284
  start-page: 13
  year: 2019
  ident: 1521_CR18
  publication-title: Psychiatry Res: Neuroimaging
  doi: 10.1016/j.pscychresns.2018.12.017
– reference: 36725866 - Neuropsychopharmacology. 2023 Apr;48(5):711-712
SSID ssj0015768
Score 2.4240277
Snippet In preclinical models of alcohol use disorder, the corticotropin-releasing factor (CRF) receptor is upregulated, particularly in the extended amygdala. This...
SourceID swepub
pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 816
SubjectTerms Addictions
Alcohol use
Alcoholism - diagnostic imaging
Alcoholism - drug therapy
Amygdala
Anxiety
Brain mapping
Clinical trials
Corticotropin-releasing hormone
Corticotropin-Releasing Hormone - metabolism
Drinking behavior
Feedback
Female
Frontal gyrus
Functional magnetic resonance imaging
Humans
Hypothalamic-pituitary-adrenal axis
Hypothalamo-Hypophyseal System - metabolism
Hypothalamus
Male
Pituitary
Pituitary-Adrenal System - metabolism
Placebos
Psychological Tests
Receptors, Corticotropin-Releasing Hormone
Social interactions
Title Corticotropin-Releasing Factor receptor 1 (CRF1) antagonism in patients with alcohol use disorder and high anxiety levels: effect on neural response during Trier Social Stress Test video feedback
URI https://www.ncbi.nlm.nih.gov/pubmed/36564531
https://www.proquest.com/docview/2793268634
https://www.proquest.com/docview/2758116961
https://pubmed.ncbi.nlm.nih.gov/PMC10066297
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-191201
Volume 48
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1tb9MwELZgkxBfEHS8FMZ0SKgCsWh1nOaFL6h0qwaIaSod6jfLSZxR0SWlaSW6v8cf4852M1WT9i2R7VaJL3fPne-eY-wtej052nXlhSkX6KDEqZdovE0L1VMJYliuTYLsWXh6EXyd9CYu4Fa7tMqNTjSKOq8yipEf-REhjTgUwaf5H4-6RtHpqmuhcZ_tEnUZSXU0aRwuTljaoMhEeOiLTVzRTFfERzUq75jSbykxAU2Yd71tmG6hzdtJk1vUosYcDR-zRw5HQt9u_BN2T5ctttcv0Ye-WkMHTGanCZm32IPv7gC9xTrnlqp6fQjjm8qr-tCsaEis13vs36Cin66WC6qo8kZonRSFFWBoGvQAKko9pwsO7wajIX8PuEXqEjVEfQXTEhxfaw0U6AVlG_HCqtaQO75PXJADsSXjxV_KHIUZJTDVH8HmmEBVArFt4lMubCIvrjVFlTCmNntgK4vhh6l2gTG-RqCiwgoKtMipyn4_ZRfDk_Hg1HMNH7wMvfQlSkmSB7obKRWmWqtCxFGQx6iUUqVQeaA68ruZyoNMJDwLiiiPMqFjxFQiRyCapuIZ2ymrUr9g4HeTAsWFhCYIsjykWFfAiyjTiDF9nrYZ3-y2zBwbOjXlmElzKi9iaSVEooRIIyHyus0-NGvmlgvkztn7GyGSTi_U8kaK2-xNM4xfNB3TqFJXK5rTizkPk5C32XMrc83fiZDYfwSOxFvS2EwgtvDtkXL6y7CGc0P2n0Rt1rGCu7XmePqzL6vFpZxNVxJ9eMSFL-9-gFfsoY-Az2Yx7bOd5WKlXyNAW6YH5is8YLufT87OR3h3_OXbf4fBPw8
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEF2VIgEvCFIugQKDBBGIWs16HV-QEIpSopZehEqK8ras7XWJSO0QJ4L0o_gJfoyZXcdVVKlvfXPkXSeOj2fO7J6ZYewVRj0p-nXl-DEXGKCEsRNp_BhnqqMi5LBcG4Hskb974n0edoZr7O8yF4ZklUubaAx1WiS0Rr7tBsQ0Ql94Hye_HOoaRburyxYaFhb7evEbQ7byw94OPt_Xrtv_NOjtOlVXASfBUHCGPyVKPd0OlPJjrVUmwsBLQ0R-rBQiFDHvthOVeomIeOJlQRokQofouEWKbCeOBV73BruJjrdNwV4wrAM8TtzdsNZIOBj7DasknbYIt0t0FiHJfUkIgS7TOV91hJfY7WWR5kopU-P--vfY3Yq3QtcC7T5b03mDbXRzjNnPFtACoyQ1S_QNduuw2rBvsNYXWxp7sQWDi0yvcsvMqItmLzbYv15Bly5mU8rgco7RGypaxoC-aQgEaJj1hA44vOkd9_lbQEioU7RI5RmMcqjqw5ZAC8ugbONfmJca0qq-KE5Igaoz48EfUqrCmART5XuwmhYocqDqnniXUyscxrkmiRMG1NYPbCYzfDXZNTDAvxEoibGADBlArJKfD9jJtUDhIVvPi1w_ZuC2owzhSSD1vCT1aW3N41mQaOS0Lo-bjC-ftkyq6uvUBGQsjQpAhNIiRCJCpEGIPG-yd_Wcia09cuXozSWIZGWHSnnx1jTZy_o0WhDaFlK5LuY0phNy7kc-b7JHFnP11wmfqg0JPBOuoLEeQNXJV8_kox-mSjk3zQWioMlaFrgrc3ZG37qymJ7K8WguecSRhz65-gZesNu7g8MDebB3tP-U3XGRbFoF1SZbn03n-hmSw1n83LyRwL5ftwn4DweQedM
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9NAEF2VVKq4IEj5CBQYJIhA1ErWdvyBhFBIGrUUoqikKLdlba9LRGqHOBGkP40rf4yZXSdVVKm33hzZ68Tx25k3u29mGHuJUU-Cfl1aXsQdDFCCyAoVfoxS2ZIhcliutEC27x2eup9GrdEW-7vKhSFZ5comakOd5DGtkTdsn5hG4DluIy1lEYNu78P0l0UdpGinddVOw0DkWC1_Y_hWvD_q4rt-Zdu9g2Hn0Co7DFgxhoVz_Flh4qqmL6UXKSVTJ_DdJMBZEEmJaEX8281YJm7shDx2Uz_xY0cF6MSdBJlPFDl431ts26eoqMK2Px70ByfrPQxi8prDho6FkeCoTNlpOkGjQNcRkPiXZBHoQK2LTbd4hetelWxuFDbVzrB3l90pWSy0DezusS2VVdluO8MI_nwJddC6Ur1gX2U7X8rt-yqrD0yh7OU-DC_zvop9PWJdQnu5y_51crp1Pp9RPpd1gr5R0qIG9HR7IEAzraZ0wOF156TH3wACRJ6hfSrOYZxBWS22AFpmBmnaAMOiUJCU1UZxQAJUqxkP_pBuFSYknyregVG4QJ4B1frEp5wZGTGO1SmdMKQmf2DymuGrzrWBIf6NQCmNOaTIByIZ_7zPTm8EDA9YJcsz9YiB3QxTBCtB1nXjxKOVNpenfqyQ4do8qjG-etsiLmuxU0uQidCaACcQBiECESI0QsRFjb1dj5maSiTXXr23ApEorVIhLudQjb1Yn0Z7QptEMlP5gq5pBZx7ocdr7KHB3PrrHI9qDzl4JthA4_oCqlW-eSYb_9A1y7luNRD6NVY3wN0Y0x1_a4t8diYm44XgIUdW-vj6B3jOdnD6i89H_eMn7LaNzNPIqfZYZT5bqKfIFOfRs3JKAvt-01bgP_R-f24
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Corticotropin-Releasing+Factor+receptor+1+%28CRF1%29+antagonism+in+patients+with+alcohol+use+disorder+and+high+anxiety+levels%3A+effect+on+neural+response+during+Trier+Social+Stress+Test+video+feedback&rft.jtitle=Neuropsychopharmacology+%28New+York%2C+N.Y.%29&rft.au=Lee%2C+Mary+R.&rft.au=Rio%2C+Daniel&rft.au=Kwako%2C+Laura&rft.au=George%2C+David+T.&rft.date=2023-04-01&rft.pub=Springer+International+Publishing&rft.issn=0893-133X&rft.eissn=1740-634X&rft.volume=48&rft.issue=5&rft.spage=816&rft.epage=820&rft_id=info:doi/10.1038%2Fs41386-022-01521-z&rft_id=info%3Apmid%2F36564531&rft.externalDocID=PMC10066297
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-133X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-133X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-133X&client=summon